Chief researcher at Huaming Pharmaceutical’s laboratory. He is given Cheng Ming’s medicine for reverse‑engineering but struggles to replicate its full efficacy. He informs CEO Chen that the best the lab can produce has only one‑thirtieth of the original drug’s effectiveness. He is dedicated but frustrated by unrealistic corporate demands.
